Compounding Pharmacy Expert Witness

A compounding pharmacy expert witness evaluates the preparation, dispensing, quality control, sterility, labeling, storage, and regulatory compliance of medications produced by compounding pharmacies and outsourcing facilities.

Compounded medications can serve important patient-specific needs, but they differ from conventional FDA-approved drug products. FDA states that compounded drugs are not FDA-approved and therefore are not reviewed by the agency for safety, effectiveness, or quality before marketing.

Litigation can involve contamination, incorrect concentrations, potency errors, sterility failures, inappropriate ingredients, beyond-use dating, dispensing mistakes, adverse reactions, recalls, or questions about whether a pharmacy complied with applicable federal and state requirements.

Blackstorm Experts helps attorneys identify pharmacists, pharmaceutical scientists, sterile compounding specialists, and related experts whose experience matches the medication and compounding process involved in the case.

What Does a Compounding Pharmacy Expert Witness Evaluate?

A compounding pharmacy expert may review prescriptions, formulation records, batch records, ingredient documentation, certificates of analysis, environmental monitoring, sterility testing, personnel training, dispensing records, storage conditions, labeling, pharmacy policies, inspection findings, and recall information.

The expert may determine whether the formulation was prepared correctly, whether appropriate ingredients and concentrations were used, whether contamination controls were adequate, and whether the medication was stored and dispensed appropriately.

The correct analysis depends heavily on whether the preparation was sterile or nonsterile and on the regulatory framework under which the compounder operated.

503A Compounding Pharmacy Cases

Section 503A of the Federal Food, Drug, and Cosmetic Act applies to qualifying human drug compounding by licensed pharmacists in state-licensed pharmacies or federal facilities, as well as certain licensed physicians.

These pharmacies generally compound medications based on valid patient-specific prescriptions and must satisfy statutory conditions to qualify for specified exemptions from federal drug requirements.

A litigation expert may evaluate whether the pharmacy was operating within the type of compounding activity permitted under the applicable framework and whether its practices complied with relevant professional and regulatory requirements.

State pharmacy law can also be critical because traditional pharmacy practice remains heavily regulated at the state level.

503B Outsourcing Facility Cases

Section 503B establishes a different framework for outsourcing facilities.

FDA describes an outsourcing facility as a facility engaged in sterile drug compounding that elects to register with FDA and meets the requirements of section 503B. Registered outsourcing facilities remain subject to current good manufacturing practice requirements.

These facilities may produce larger quantities of compounded medications for healthcare facilities rather than operating solely around individual patient prescriptions.

A 503B case may therefore resemble pharmaceutical manufacturing litigation more closely than a traditional community pharmacy dispute.

The expert should understand which regulatory framework applied because standards and obligations can differ substantially between 503A pharmacies and 503B outsourcing facilities.

Sterile Compounding Expert Witness

Sterile compounding includes medications intended for routes of administration where microbial contamination can create significant risk.

USP General Chapter <797> addresses sterile compounding and includes requirements concerning personnel responsibilities, training, facilities, environmental monitoring, and other controls intended to reduce contamination risk.

Cases may involve injectable medications, ophthalmic preparations, infusions, pain medications, or other sterile products.

The expert may evaluate cleanroom practices, aseptic technique, environmental monitoring, personnel competency, sterilization methods, storage, and beyond-use dating.

A serious contamination case may also require microbiology or infectious disease expertise.

Nonsterile Compounding

Not all compounded medications are sterile.

Nonsterile preparations can include capsules, creams, ointments, oral liquids, suppositories, and other customized formulations.

USP General Chapter <795> establishes standards for nonsterile compounding intended to reduce risks such as contamination, infection, and incorrect preparation.

A malpractice case may involve inaccurate concentrations, ingredient substitution, cross-contamination, improper mixing, inappropriate storage, or incorrect beyond-use dating.

The expert may reconstruct the formulation process to determine where the alleged error occurred.

Compounding Contamination Cases

Contamination can occur through ingredients, equipment, personnel, surfaces, air handling, containers, or failures in the preparation environment.

In sterile medications, microbial contamination can produce severe infections because the drug may be injected directly into the body or administered to vulnerable tissue.

The expert may review environmental sampling, sterility testing, cleaning records, workflow, personnel training, and batch history to determine whether contamination controls were adequate.

If several patients receiving products from the same batch develop similar infections, epidemiological and microbiological evidence may become particularly important.

Incorrect Drug Concentration

Compounded medications often require calculations and measurements that differ from commercially manufactured products.

A case may involve a medication containing substantially more or less active ingredient than intended.

The expert may examine the prescription, formula, calculations, weighing and measuring procedures, dilution steps, equipment calibration, final testing, and dispensing records.

A concentration error can result from the original formulation, transcription, measurement, dilution, or labeling.

Identifying where the error occurred can be essential when responsibility is disputed among the pharmacy, prescriber, and healthcare facility.

Potency Errors

Potency refers to the amount of active drug contained in the preparation relative to the intended formulation.

A preparation that is super-potent may expose the patient to excessive drug effects, while a sub-potent preparation may fail to provide adequate treatment.

A pharmaceutical or compounding expert may evaluate formulation records and analytical testing to determine whether the medication met expected specifications.

Medical experts may separately be required to establish whether the potency deviation actually caused the patient's injury.

Wrong Ingredient Cases

Compounding requires accurate identification and use of ingredients.

A preparation may contain the wrong active ingredient, incorrect strength, unsuitable excipient, or another unintended substance.

FDA imposes specific conditions concerning bulk drug substances that may be used by compounders operating under section 503A.

An expert may review purchasing records, ingredient labels, certificates of analysis, inventory systems, formulation worksheets, and technician or pharmacist documentation.

Beyond-Use Dating

Compounded medications are assigned beyond-use dates rather than relying simply on expiration dates used for commercially manufactured products.

Beyond-use dating considers the preparation type, stability, storage conditions, formulation, and applicable compounding standards.

A case may involve medication dispensed or administered after an inappropriate beyond-use date or a preparation stored under conditions inconsistent with its assigned dating.

The expert may determine whether the pharmacy's dating and storage practices were supportable for the particular preparation.

Storage and Temperature Control

Some compounded medications require refrigeration or other controlled storage conditions.

Temperature excursions can affect chemical stability, potency, or microbial growth depending on the medication.

A pharmacy expert may review refrigerator logs, shipping records, packaging, temperature monitoring, and instructions provided to the patient or healthcare facility.

If the medication passed through several entities before administration, the expert may need to determine whether the alleged storage failure occurred at the pharmacy, during transportation, or after delivery.

Compounded Injectable Medications

Injectable compounded medications can create particularly significant risks because sterility, concentration, and formulation accuracy are critical.

Cases may involve pain injections, intravenous medications, anesthesia drugs, hormone preparations, or other injectable products.

The expert may assess both preparation quality and whether appropriate testing occurred before distribution.

When the patient develops infection, toxicity, or neurological injury, separate medical experts may be required to address the resulting condition.

Ophthalmic Compounding Cases

Compounded medications may also be prepared for use in or around the eye.

Contamination, incorrect concentration, or formulation problems can create risk of serious ocular injury.

A compounding pharmacist may evaluate preparation procedures while an ophthalmologist determines whether the medication caused the claimed eye injury.

Because ophthalmic administration can involve particularly sensitive tissue, sterility and formulation issues may receive close scrutiny.

Compounded Hormone Cases

Compounding pharmacies sometimes prepare individualized hormone formulations.

Litigation may involve dosing, formulation, labeling, dispensing, or claims concerning whether a preparation matched the prescriber's order.

A pharmacy expert may evaluate the compounding process itself.

An endocrinologist, gynecologist, or other prescribing specialist may be necessary when the dispute concerns whether the medication should have been prescribed or whether it caused a particular medical effect.

Compounded GLP-1 Drug Cases

Compounded versions of GLP-1 medications have received substantial regulatory attention as shortages and availability of FDA-approved products have changed.

FDA has emphasized that compounded drugs must satisfy the conditions of sections 503A or 503B to qualify for applicable statutory exemptions and has issued updated policies as GLP-1 shortages stabilized.

A dispute may involve formulation, ingredient sourcing, dosing, labeling, or whether compounding was permitted under the circumstances.

Because this regulatory area can change, an expert should evaluate the rules and FDA policies in effect at the time of the alleged conduct rather than relying on current conditions alone.

Pharmacy Recall Cases

Compounded medications may be recalled when sterility, potency, labeling, contamination, or other quality concerns are identified.

FDA maintains information concerning inspections, recalls, warning actions, and other enforcement activity involving compounders.

A recall can provide important evidence but does not automatically establish that a particular patient's medication was defective.

The expert may determine whether the medication came from an affected lot, whether the identified defect matches the alleged injury, and whether exposure actually occurred.

Pharmacy Inspection Records

State boards of pharmacy and FDA may inspect facilities depending on the type of compounder and applicable jurisdiction.

Inspection records can identify concerns involving cleanrooms, documentation, environmental controls, ingredients, training, testing, or other practices.

An expert should distinguish an inspection observation from proof that the same condition caused the patient's injury.

The strongest analysis connects the alleged operational deficiency to the actual medication and harm at issue.

USP <795> and <797>

USP standards frequently arise in compounding litigation.

USP <795> addresses nonsterile preparations, while USP <797> addresses sterile preparations.

Their relevance can depend on the jurisdiction, facility, preparation, and time period involved.

An expert should identify which standards applied rather than citing USP generically.

State adoption and enforcement of USP provisions can vary, so regulatory context matters.

Hazardous Drug Compounding

Some compounded preparations involve drugs that pose occupational or environmental hazards to healthcare workers.

USP's compounding framework also includes Chapter <800>, which addresses handling of hazardous drugs in healthcare settings.

Cases may involve containment, personal protective equipment, preparation areas, exposure, or contamination.

An occupational safety or industrial hygiene expert may supplement a pharmacist when worker exposure rather than patient medication quality is the central issue.

Compounding Pharmacist Versus Pharmacologist

A compounding pharmacist is generally the stronger expert for pharmacy workflow, formulation, dispensing, sterile technique, documentation, and professional pharmacy standards.

A pharmacologist may be more useful when the central dispute concerns how a drug acts in the body, dose-response relationships, metabolism, or drug interactions.

Some cases need both.

The pharmacy expert determines whether the medication was prepared correctly, while the pharmacologist or physician addresses what effect the preparation would be expected to have on the patient.

Pharmacy Expert Versus Infectious Disease Expert

A pharmacist may determine whether sterile compounding practices created a contamination risk.

An infectious disease physician can evaluate whether the patient's infection was medically consistent with exposure to the contaminated product.

Microbiology may also become important when organisms recovered from patients can be compared with organisms associated with a medication or compounding environment.

Separating these roles can produce a cleaner causation analysis.

Plaintiff Compounding Pharmacy Expert Witnesses

Plaintiff attorneys may retain a compounding pharmacy expert to determine whether a medication was improperly formulated, contaminated, mislabeled, inadequately tested, or prepared under inappropriate conditions.

The expert may also evaluate whether pharmacy procedures complied with applicable compounding standards and whether a documented failure provides a plausible mechanism for the patient's injury.

A medical expert may still be needed to connect the medication defect to the claimed damages.

Defense Compounding Pharmacy Expert Witnesses

Defense attorneys may retain a compounding expert to determine whether the preparation process was appropriate, whether laboratory testing supports the alleged defect, or whether the patient's medication was actually part of an affected batch.

The expert may also distinguish between regulatory observations and deficiencies that could realistically have caused the injury.

Alternative sources of contamination, medication handling after dispensing, and underlying medical conditions may also become relevant.

Choosing a Compounding Pharmacy Expert Witness

The expert should match the type of compounding involved.

A sterile injectable case may require someone with extensive USP <797> and cleanroom experience.

A nonsterile formulation case may favor a pharmacist experienced with USP <795> preparations.

A 503B outsourcing facility dispute may require deeper knowledge of FDA regulation and pharmaceutical manufacturing requirements.

The strongest expert is generally someone who currently performs, supervises, audits, or regulates compounding similar to the activity being challenged.

Find a Compounding Pharmacy Expert Witness

Compounding pharmacy cases can involve sterile and nonsterile medications, contamination, potency errors, incorrect concentrations, ingredient problems, beyond-use dating, storage, recalls, USP standards, 503A pharmacies, and 503B outsourcing facilities.

Blackstorm Experts helps attorneys identify compounding pharmacy expert witnesses whose current experience matches the medication, facility, and regulatory issues involved in the matter.

Send us the compounded drug, type of pharmacy or outsourcing facility, alleged preparation failure, and claimed injury. We can identify pharmacists, pharmaceutical scientists, microbiologists, and related experts whose backgrounds fit the case.

Start an expert witness search